Meyer Vitabiotics Study Shows 76% Improvement in Male Fertility with Antioxidant Micronutrients
New Delhi, India – May 3: A groundbreaking study conducted by Meyer Vitabiotics, an Indian nutraceutical leader, has revealed that a combination of antioxidant micronutrients and vitamins improved male fertility by 76%. This remarkable improvement was seen even in severe cases of male infertility. The study, which was conducted over a three-month period, involved 300 Indian males with varied types and degrees of infertility, and it showed that a blend of multivitamins, minerals, essential amino acids, ginseng, and lycopene increased sperm count by 75.76% in men with a baseline sperm count of less than 5 million/ml. These findings mark a major step forward in addressing male infertility in India, an area often neglected in traditional treatments.
The clinical trial, titled “Impact of Antioxidants in Improving Semen Parameters like Count, Motility, and DNA Fragmentation in Sub-Fertile Males: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial”, was conducted by Meyer Vitabiotics at 10 different sites across India. The study was published in the international journal Translational and Clinical Pharmacology, providing scientific backing for the use of nutraceuticals in male fertility treatment.
Dr. Ameet Patki, the principal investigator of the study, emphasized the importance of this research, stating, “Male infertility accounts for 20–30% of all infertility cases. Conditions like Oligospermia (low sperm count), Asthenozoospermia (sperm motility issues), and Teratozoospermia (abnormal sperm) are common causes of infertility in men. While surgical procedures and hormonal treatments exist, they often come with high costs, uncertain effectiveness, and potential side effects. This study demonstrates the potential of antioxidants to improve fertility parameters without these drawbacks.”
Mr. Rohit Shelatkar, Vice President of Meyer Vitabiotics, highlighted the significance of the study in addressing global infertility concerns. “Infertility is a serious challenge worldwide, and existing treatments often fail to provide a cost-effective or efficient solution. Our study showed the efficacy of antioxidant blends, like Oligocare Forte Plus (also marketed as Wellman Conception in the UK), in improving sperm count, motility, and DNA fragmentation index. With ingredients such as vitamins E & C, carnitine, N-acetyl cysteine, selenium, and zinc, this blend offers a clinically effective, non-invasive alternative to traditional treatments.”
The study’s success reflects Meyer Vitabiotics’ commitment to improving male reproductive health. It was a multi-centric trial conducted under strict adherence to Good Clinical Practices (GCP) and relevant regulatory guidelines, involving a team of highly skilled investigators, including Dr. Monica Singh, Dr. Sweta Agarwal, Dr. Venugopal M, Dr. Shashikant Umbardand, Dr. Apoorva Reddy, Dr. Priya Kannan, Dr. Srilatha Gorthi, Dr. Gautam Khastgir, and Dr. Anita Kulshreshtha.
The positive results of this study have opened the door for more research into nutraceutical interventions in male infertility and provide hope for many men struggling with fertility issues.
About Meyer Vitabiotics:
Meyer Vitabiotics, part of the UK’s leading vitamin company Vitabiotics Ltd, is committed to enhancing human health through innovative nutritional supplements. Founded in London, Vitabiotics has been at the forefront of creating pioneering vitamin and mineral supplements, available in over 110 countries worldwide. Products like Calcimax, Colicaid, Jointace, Wellman, Wellwoman, Ultra D3, Perfectil, Pregnacare, and Menopace have become market leaders in their respective segments. Meyer Vitabiotics is dedicated to providing clinical evidence-based supplements that improve therapeutic outcomes across all age groups.
For more information about Meyer Vitabiotics and their products, visit www.meyervitabiotics.com.
For any concerns regarding this press release, please contact us at pr.error.rectification[at]gmail.com. We will respond and resolve any issues within 24 hours.
Rajneesh Singh is a journalist at Asian News, specializing in entertainment, culture, international affairs, and financial technology. With a keen eye for the latest trends and developments, he delivers fresh, insightful perspectives to his audience. Rajneesh’s passion for storytelling and thorough reporting has established him as a trusted voice in the industry.
